Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website. (MIBS trial)

Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website. (MIBS trial)

Show other versions (1)

<p>Abstract</p> <p>Background</p> <p>IBS affects 10-22% of the UK population. Abdominal pain, bloating and altered bowel habit affect quality of life, social functioning and time off work. Current GP treatment relies on a positive diagnosis, reassurance, lifestyle advic...

Full description

Bibliographic Details
Main Authors: Yardley Lucy, Coleman Nicholas S, Tapp Laura, Sibelli Alice, Moss-Morris Rona E, Everitt Hazel A, Smith Peter W, Little Paul S
Format: Article
Language:English
Published: BMC 2010-11-01
Series:BMC Gastroenterology
Online Access:http://www.biomedcentral.com/1471-230X/10/136

Similar Items

Similar Items